| A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension. | |
MedLine Citation:
|
PMID: 10214534 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We examined the effects of avitriptan, a 5-hydroxytryptamine 1-like (5HT1) receptor agonist for the treatment of migraine, in patients with medicated, controlled, mild to moderate hypertension relative to placebo and sumatriptan. The study was randomized, double-blinded, placebo-controlled, and 4-way crossover in design. Twenty patients (12M, 8F) participated. As required by protocol, all were stable on medications for mild to moderate hypertension, with a supine diastolic blood pressure of < 95 mmHg. Qualified subjects were randomized to receive oral administration of either 75 or 150 mg of avitriptan, 100 mg sumatriptan or placebo during the four treatment visits. Supine blood pressure and pulse rates were recorded up to 24 h after drug administration. Avitriptan 150 mg significantly increased peak diastolic and systolic blood pressure, and mean arterial pressure compared to placebo and sumatriptan 100 mg (p < 0.05). Only those hypertensive patients receiving medication for hypertension should receive anti-migraine medications, such as avitriptan, which are 5HT1-like receptor agonists. |
Authors:
|
S S Jhee; D E Salazar; N F Ford; I E Fulmor; J J Sramek; N R Cutler |
Related Documents
:
|
12119484 - Efficacy and safety of losartan in patients with proteinuria. 15042114 - Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systo... 2877644 - Relaxation therapy for hypertension. comparison of effects with concomitant placebo, di... 9403364 - Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain. 21107584 - Daytime baroreflex sensitivity in patients with primary insomnia. 24304594 - Rise of intraocular pressure in a caffeine test versus the water drinking test in patie... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Cephalalgia : an international journal of headache Volume: 19 ISSN: 0333-1024 ISO Abbreviation: Cephalalgia Publication Date: 1999 Mar |
Date Detail:
|
Created Date: 1999-06-01 Completed Date: 1999-06-01 Revised Date: 2008-02-11 |
Medline Journal Info:
|
Nlm Unique ID: 8200710 Medline TA: Cephalalgia Country: NORWAY |
Other Details:
|
Languages: eng Pagination: 95-9 Citation Subset: IM |
Affiliation:
|
California Clinical Trials, Beverly Hills, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Blood Pressure / drug effects*, physiology Double-Blind Method Female Humans Hypertension / drug therapy*, physiopathology Indoles / administration & dosage* Male Middle Aged Sulfonamides / administration & dosage* Sumatriptan / administration & dosage* Tryptamines |
| Chemical | |
Reg. No./Substance:
|
0/Indoles; 0/Sulfonamides; 0/Tryptamines; 103628-46-2/Sumatriptan; 171171-42-9/BMS 180048 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cluster headache and lifestyle: remarks on a population of 374 male patients.
Next Document: Effects of zolmitriptan (Zomig) on central serotonergic neurotransmission as assessed by active oddb...